ABSTRACT
En los últimos años se están haciendo notables esfuerzos para entender la relación existente entre la psoriasis y la esteatosis hepática metabólica (EHmet). No solo se presenta este trastorno en pacientes psoriásicos con una mayor prevalencia, sino que además se acompaña de una mayor gravedad. Con este precedente, se evidencia la necesidad de establecer un protocolo de abordaje precoz de la enfermedad hepática en los pacientes con psoriasis. Asimismo, es de especial relevancia la evaluación de riesgo y beneficio en referencia al uso de tratamientos con potencial hepatotóxico. En el presente manuscrito se exponen las recomendaciones de un panel de expertos en dermatología y hepatología para el cribado, diagnóstico, monitorización y criterios de derivación en pacientes con psoriasis, en caso de sospecha de esteatosis hepática metabólica (AU)
Recent years have seen concerted efforts to understand the relation between psoriasis and metabolic-associated fatty liver disease (MAFLD). Not only is MALFD diagnosed more often in patients with psoriasis, but its clinical course is also more aggressive. A common approach is therefore needed to enable early detection of liver disease coincident with psoriasis. Especially important is an analysis of risks and benefits of potentially hepatotoxic treatments. This consensus paper presents the recommendations of a group of experts in dermatology and hepatology regarding screening for MALFD as well as criteria for monitoring patients and referring them to hepatologists when liver disease is suspected (AU)
Subject(s)
Humans , Psoriasis/complications , Psoriasis/therapy , Fatty Liver/etiology , Fatty Liver/therapy , Risk Factors , Consensus , SpainABSTRACT
Recent years have seen concerted efforts to understand the relation between psoriasis and metabolic-associated fatty liver disease (MAFLD). Not only is MALFD diagnosed more often in patients with psoriasis, but its clinical course is also more aggressive. A common approach is therefore needed to enable early detection of liver disease coincident with psoriasis. Especially important is an analysis of risks and benefits of potentially hepatotoxic treatments. This consensus paper presents the recommendations of a group of experts in dermatology and hepatology regarding screening for MALFD as well as criteria for monitoring patients and referring them to hepatologists when liver disease is suspected (AU)
En los últimos años se están haciendo notables esfuerzos para entender la relación existente entre la psoriasis y la esteatosis hepática metabólica (EHmet). No solo se presenta este trastorno en pacientes psoriásicos con una mayor prevalencia, sino que además se acompaña de una mayor gravedad. Con este precedente, se evidencia la necesidad de establecer un protocolo de abordaje precoz de la enfermedad hepática en los pacientes con psoriasis. Asimismo, es de especial relevancia la evaluación de riesgo y beneficio en referencia al uso de tratamientos con potencial hepatotóxico. En el presente manuscrito se exponen las recomendaciones de un panel de expertos en dermatología y hepatología para el cribado, diagnóstico, monitorización y criterios de derivación en pacientes con psoriasis, en caso de sospecha de esteatosis hepática metabólica (AU)
Subject(s)
Humans , Psoriasis/complications , Psoriasis/therapy , Fatty Liver/etiology , Fatty Liver/therapy , Risk Factors , Consensus , SpainABSTRACT
Recent years have seen concerted efforts to understand the relation between psoriasis and metabolic-associated fatty liver disease (MAFLD). Not only is MALFD diagnosed more often in patients with psoriasis, but its clinical course is also more aggressive. A common approach is therefore needed to enable early detection of liver disease coincident with psoriasis. Especially important is an analysis of risks and benefits of potentially hepatotoxic treatments. This consensus paper presents the recommendations of a group of experts in dermatology and hepatology regarding screening for MALFD as well as criteria for monitoring patients and referring them to hepatologists when liver disease is suspected.
Subject(s)
Gastroenterology , Non-alcoholic Fatty Liver Disease , Psoriasis , Humans , Consensus , Non-alcoholic Fatty Liver Disease/complications , Non-alcoholic Fatty Liver Disease/diagnosis , Patients , Psoriasis/complicationsABSTRACT
There is a well-established association of vitiligo with autoimmune conditions, and circulating autoantibodies to melanocytes have been demonstrated in the serum of patients with vitiligo. We present a case of repigmentation of vitiligo lesions in a girl with celiac disease after initiating a gluten-free diet, which to our knowledge has not been reported.
Subject(s)
Celiac Disease/diet therapy , Diet, Gluten-Free , Skin Pigmentation/immunology , Vitiligo/immunology , Vitiligo/pathology , Celiac Disease/immunology , Child , Female , Humans , Recovery of Function/immunologySubject(s)
Tattooing/adverse effects , Warts/diagnosis , Adolescent , Diagnosis, Differential , Female , Humans , Leg/pathology , Warts/etiology , Warts/pathologyABSTRACT
Naevus lipomatosus cutaneous superficialis (NLCS) is an uncommon hamartomatous lesion with an exceptional presentation on the face. We report the case of an elderly patient who presented with a classic type of NLCS on the right nasal orifice. This patient was taking inhaled steroids for his allergic rhinitis during 35 years.
Subject(s)
Lipomatosis/diagnosis , Nevus/diagnosis , Nose Neoplasms/diagnosis , Administration, Inhalation , Aged , Diagnosis, Differential , Humans , Lipomatosis/pathology , Lipomatosis/surgery , Male , Nevus/pathology , Nevus/surgery , Nose Neoplasms/pathology , Nose Neoplasms/surgery , Rhinitis, Allergic, Perennial/drug therapy , Steroids/administration & dosageABSTRACT
BACKGROUND: An intermittent short course of cyclosporin A (CyA) therapy is a good choice in the treatment of severe psoriasis. Nevertheless, some severe or resistant patients might benefit from long-term treatment. Adverse effects of long-term use of CyA are investigated and the results are compared with the literature. PATIENTS AND METHODS: A retrospective study of adverse effects of CyA treatment in a group of 53 patients suffering from psoriasis. The mean treatment time was 31.4 +/- 23.2 months with a minimum of 4 months to a maximum of 95 months, with very few short interruptions of treatment (from 2 to 5 months in five patients). RESULTS: The group consisted of 29 women and 24 men, ranging in age from 18 to 65 years, with an average age of 44.49 years. Arterial hypertension appeared in 45.3% of patients during treatment. Pharmacological treatment was required in 32% of these patients to control the condition. Serum creatinine levels were transiently elevated in 11.3% of the cases, but withdrawal of treatment was required in none of them. DISCUSSION: Long-term CyA treatment might be necessary in some patients and this study shows that it could be sustained with a close follow-up. This involves regular visits depending on each patient, as well as common test protocol and clinical evaluation. In conclusion, this retrospective study seems to confirm the relative safety of long-term CyA treatment when patients are adequately monitored.
Subject(s)
Cyclosporine/therapeutic use , Dermatologic Agents/therapeutic use , Immunosuppressive Agents/therapeutic use , Psoriasis/drug therapy , Adolescent , Adult , Aged , Chronic Disease , Cyclosporine/adverse effects , Dermatologic Agents/adverse effects , Female , Humans , Immunosuppressive Agents/adverse effects , Male , Middle Aged , Retrospective StudiesSubject(s)
Sweet Syndrome/chemically induced , Adolescent , Adult , Aged , Child , Child, Preschool , Female , Humans , Male , Middle Aged , Sweet Syndrome/diagnosis , Sweet Syndrome/therapySubject(s)
Contraceptives, Oral/adverse effects , Sweet Syndrome/chemically induced , Adult , Drug Therapy, Combination , Female , Follow-Up Studies , Humans , Menstruation Disturbances/drug therapy , Mometasone Furoate , Prednisone/administration & dosage , Pregnadienediols/administration & dosage , Sweet Syndrome/drug therapy , Treatment OutcomeABSTRACT
El conocimiento y correcto empleo de las diferentes técnicas de radioterapia suponen una gran ayuda en el manejo de los pacientes con carcinomas basocelulares. En nuestro Servicio continuamos empleando la técnica de radioterapia de contacto para estas neoplasias en un número elevado de enfermos. Hemos recogido los datos referentes a los tumores tratados durante los años 1997, 1998 y 1999, un total de 279, y hemos analizado los datos epidemiológicos de la muestra, edad, sexo y fototipo, así como tamaño, tipo clínico, localización, cicatrización y recidivas de los tumores. Empleamos una técnica desarrollada por nuestro equipo, consistente en tres sesiones de 10 Gy, hasta un total de 30 Gy, lo cual supone un buen balance entre la comodidad del enfermo y los resultados médicos en tasas de curación y resultado estético de las cicatrices. Los pacientes tratados fueron en su mayoría de pelo oscuro en la edad adulta y ojos claros. Hemos tratado lesiones de 0,5 a 3,5 cm de diámetro con un 5% de recidivas y un 22,3% de cicatrices imperceptibles (AU)
Subject(s)
Carcinoma, Basal Cell/therapy , Radiotherapy/methodsABSTRACT
Paracoccidioidomycosis is a common fungal infection in Latin America. Few cases have been described in non-endemic countries and their diagnosis without the correct suspicion, bearing in mind that the latency period might be up to 60 years, may not be easy. We report the case of a 59-year-old man who worked as a taxi driver for 25 years in Venezuela. Cutaneous paracoccidioidomycosis was diagnosed one year after he returned to Spain. No internal signs or symptoms of the disease were found and cell-mediated immunity showed no depression. Our case suggested us to consider direct cutaneous infection, although respiratory tract is believed to be the most frequent portal of entry for this infection.
Subject(s)
Paracoccidioidomycosis , Humans , Male , Middle Aged , Paracoccidioidomycosis/diagnosis , Paracoccidioidomycosis/drug therapy , Paracoccidioidomycosis/pathology , Skin/pathologyABSTRACT
Las linfangiectasias cutáneas se han descrito clásicamente como una rara complicación tras mastectomía radical o tratamiento radioterápico o quirúrgico de carcinomas de cervix con o sin linfadenectomía. El principal factor desencadenante que se ha barajado es la obstrucción linfática profunda. Con posterioridad han aparecido en la literatura algunos casos cuyos antecedentes parecen tener más relación con factores locales en la matriz intercelular dérmica, que con daño profundo del sistema linfático.Describimos el caso de un linfangioma adquirido localizado en vulva tras una histerectomía radical con radioterapia posterior debido a un carcinoma de cervix y discutiremos la etiopatogenia de esta entidad (AU)
Subject(s)
Female , Middle Aged , Humans , Lymphangiectasis/etiology , Hysterectomy/adverse effects , Lymphangiectasis/diagnosis , Lymphangiectasis/pathology , Lymphangiectasis/radiotherapy , Vulva/pathology , Postoperative Complications , Carcinoma, Squamous Cell/surgery , Lymph Node Excision/methods , Radiotherapy/methodsABSTRACT
Only a few reports of primary cutaneous rhabdoid tumors have been published. We describe the case of a 3-month-old female patient who developed a rhabdoid type cutaneous sarcomatoid neoplasm in her upper back, close to a benign myofibromatous proliferation of infancy. The lesion was studied both by light microscopy and immunohistochemically. Flow cytometry was performed showing a DNA diploid profile of the malignant tumor. The pathological findings suggest a mesenchymal origin (hemangiopericytic or myofibroblastic type) for both tumors. The patient was surgically treated, but she died nine months later.
